Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base.

January 13, 2022 — Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base. Lunit recently received FDA 510 (k) clearance for Lunit Insight MMG, for detecting breast cancer, and Lunit CXR Triage, a Chest X-ray solution developed for sorting and prioritizing emergency cases. 

By partnering with Lunit, Infinitt can offer an enhanced integration with the AI solutions, enabling radiologists and ER clinicians to apply the algorithms and machine learning seamlessly, without any disruption in workflow.

Developed using Lunit’s deep learning technology, Lunit Insight MMG accurately analyses mammography images to detect lesions that could indicate breast cancer and provides location information for any detected lesions in the form of outlines and heatmaps. The computer-assisted diagnostic software has shown excellent performance in the early detection of breast cancer.

Lunit Insight CXR Triage chest detection suite accurately detects pre-specified suspected critical findings in chest X-ray's (pleural effusion and/or pneumothorax), quickly identifying critical conditions needing immediate attention. The algorithm performs at a 98-99% accuracy rate. 

David Smarro, President and CEO of Infinitt North America, is pleased to be partnering with a leading AI developer, marketing solutions that have already received FDA clearance. 

“Artificial Intelligence has so much potential in imaging informatics, both as a diagnostic tool and in getting all relevant patient data to the right clinician or subspecialist as quickly as possible. Earlier and more accurate diagnosis, earlier treatment, and a more patient-centered approach to care will improve clinical outcomes and reduce healthcare costs,” said Smarro.

With Lunit Insight MMG, rapid triage of screening mammograms will filter out benign cases for later evaluation, helping to reduce strain on radiologists as 60% of screening mammograms come up normal. 

For more information: www.infinittna.com/

 

 


Related Content

News | Stroke

Dec. 18, 2025 — Brainomix, a provider of AI-powered imaging biomarkers for stroke and lung fibrosis, has announced ...

Time December 24, 2025
arrow
News | Information Technology

Dec. 16, 2025 — McCrae Tech has launched the world’s first health AI orchestrator called Orchestral. It is a health ...

Time December 23, 2025
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | RSNA 2025

Dec. 12, 2025 — At RSNA 2025, United Imaging Intelligence (UII), the AI-focused subsidiary of United Imaging Group ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
Feature | Radiation Oncology | Kyle Hardner

Genomics has guided personalized cancer treatments for the past two decades. Now, AI biomarkers are expanding the field ...

Time December 09, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
Subscribe Now